Bifidobacterium pseudocatenulatum LI09
Bifidobacterium pseudocatenulatum LI09 has been investigated in animal models examining liver health and gut microbiota composition. Rat studies involving chemically induced liver injury have examined changes in gut bacterial and fungal communities and liver damage markers in relation to LI09 administration. All available evidence is from animal models, and no human clinical data for this strain were identified. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 3 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
3 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 35127946 →Multiple Intestinal Bacteria Associated with the Better Protective Effect of Bifidobacterium pseudocatenulatum LI09 against Rat Liver Injury· BioMed Research International · 2022
-
[2]
PMID 35401547 →Characterising the Intestinal Bacterial and Fungal Microbiome Associated With Different Cytokine Profiles in Two Bifidobacterium strains Pre-Treated Rats With D-Galactosamine-Induced Liver Injury· Frontiers in Immunology · 2022
-
[3]
PMID 28821814 →Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota· Scientific Reports · 2017